BSE Live
Jan 14, 16:01Prev. Close
1420.85
Open Price
1420.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 14, 15:58Prev. Close
1421.00
Open Price
1424.40
Bid Price (Qty.)
1410.20 (24)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Dr Lal PathLabs (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 15.37 | 13.16 | 8.55 | 6.69 | 4.57 | |
| Diluted EPS (Rs.) | 10.71 | 9.05 | 6.02 | 5.09 | 3.47 | |
| Cash EPS (Rs.) | 21.93 | 196.36 | 2,002.89 | 1,762.43 | 1,193.01 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 53.56 | 352.41 | 4,476.48 | 3,290.36 | 2,680.95 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 53.56 | 352.41 | 4,476.48 | 3,290.36 | 2,680.95 | |
| Dividend / Share(Rs.) | 1.53 | 10.64 | 154.28 | 257.00 | 164.28 | |
| Revenue from Operations/Share (Rs.) | 116.53 | 1,007.46 | 12,553.50 | 9,514.87 | 6,623.11 | |
| PBDIT/Share (Rs.) | 29.93 | 266.45 | 2,664.73 | 2,425.49 | 1,636.43 | |
| PBIT/Share (Rs.) | 24.10 | 207.86 | 2,118.62 | 1,885.74 | 1,281.42 | |
| PBT/Share (Rs.) | 24.03 | 207.42 | 2,107.98 | 1,811.06 | 1,264.12 | |
| Net Profit/Share (Rs.) | 16.10 | 137.77 | 1,456.78 | 1,222.68 | 838.00 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 25.68 | 26.44 | 21.22 | 25.49 | 24.70 | |
| PBIT Margin (%) | 20.68 | 20.63 | 16.87 | 19.81 | 19.34 | |
| PBT Margin (%) | 20.62 | 20.58 | 16.79 | 19.03 | 19.08 | |
| Net Profit Margin (%) | 13.81 | 13.67 | 11.60 | 12.85 | 12.65 | |
| Return on Networth / Equity (%) | 30.06 | 39.09 | 32.54 | 37.15 | 31.25 | |
| Return on Capital Employed (%) | 25.95 | 31.31 | 29.15 | 33.39 | 27.31 | |
| Return on Assets (%) | 19.58 | 22.32 | 19.38 | 24.07 | 17.27 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 | |
| Asset Turnover Ratio (%) | 141.72 | 163.22 | 167.04 | 187.31 | 136.56 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.50 | 1.74 | 1.27 | 0.86 | 0.77 | |
| Quick Ratio (X) | 2.38 | 1.63 | 1.18 | 0.75 | 0.65 | |
| Inventory Turnover Ratio (X) | 46.46 | 49.10 | 53.41 | 56.94 | 31.10 | |
| Dividend Payout Ratio (NP) (%) | 9.52 | 7.72 | 10.59 | 21.02 | 19.60 | |
| Dividend Payout Ratio (CP) (%) | 6.99 | 5.42 | 7.70 | 14.58 | 13.76 | |
| Earnings Retention Ratio (%) | 90.48 | 92.28 | 89.41 | 78.98 | 80.40 | |
| Cash Earnings Retention Ratio (%) | 93.01 | 94.58 | 92.30 | 85.42 | 86.24 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 90.47 | 92.27 | 89.40 | 78.97 | 80.39 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
05.12.2025
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak